Federal officials to young people: Stop spreading COVID-19

As the numbers of positive COVID-19 cases soars across the South, federal officials today implored young people to be more careful about spreading the disease.

Members of the White House Coronavirus Task Force, holding their first public briefing in two months, spoke of the risks of continuing to spread the virus by people who are the least at risk for serious complications and death to those who are.

Although Drs. Deborah Birx and Anthony Fauci said they weren’t blaming anyone for spreading the virus, they clearly singled out millennials, who have begun returning to bars and other social venues in states that have opened their economies. Fauci also noted that the greatest increase in cases is coming in people under 40.

“Anyone who gets infected or is at risk of getting infected, to a greater or lesser degree, is part of the dynamic process of the outbreak,” he said. “A risk for you is not just isolated to you. Because if you are infected, you are in dan…

Read more
  • 0

20 medical device startups you need to know

The medtech industry isn’t immune from COVID-19 troubles, but exciting innovation continues. These 20 medical device startups have grabbed our attention.

Tom Salemi, DeviceTalks Editorial Director and Sean Whooley, Assistant Editor

A number of medical device startups continue to make waves across the space, with new technologies and eye-watering fundraising rounds highlighting some exciting prospects.

From treating children with congenital heart disease to therapy that alleviates the effects of traumatic nightmares — and with plenty more innovations between — there is no shortage of intriguing medical devices and therapies coming up through the ranks.

“Even in the face of the COVID-19 pandemic, we continue to see tremendous energy in the medtech innovation ecosystem,” said Paul Grand, CEO of MedTech Innovator. “We are noticing a strong trend of minimally invasive medical devices that improve patient outcomes and require less time spent in th…

Read more
  • 0

$4.2m project with GE would develop air transport vital-signs patch

The Nano-Bio Materials Consortium (NBMC) announced this week that it has launched a project with GE Research to develop a medical-grade wireless patch that monitors the vital signs of medical patients during emergency air transport.

The device would advance medical care coordination, records management and patient outcomes in aeromedical evacuation and help drive advances in consumer-based telehealth, according to the Milpitas, Calif.-based consortium. The 24-month project is funded at $4.22 million by the consortium, GE Research, the State of New York, State University of New York at Binghamton, DuPont and UES.

Get the full story on our sister site, Medical Design & Outsourcing.

Read more
  • 0

Soliton announces public offering

Soliton (NSDQ:SOLY) announced that it intends to offer an undisclosed amount of shares of its common stock in an underwritten public offering.

The Houston-based medical device company also intends to grant underwriters a 30-day option to purchase up to an additional 15% of the number of shares offered.

Cantor Fitzgerald & Co. is acting as the sole book-running manager for the proposed offering, according to a news release.

Soliton develops an FDA-cleared device that uses rapid pulses of acoustic shockwaves as an accessory to lasers for the removal of unwanted tattoos. It is engaged in bringing the Rapid Acoustic Pulse device to the market and completed a clinical study using the system to improve the appearance of cellulite.

Read more
  • 0

Partnership will study use of existing drugs for COVID-19 and and more

A new collaboration funded by in part by $1.1 million from the FDA is working on finding new uses for existing drugs for areas of high unmet medical need — with a pilot project focused on treatments for COVID-19.

The Critical Path Institute (C-Path) this week announced the launch of the CURE Drug Repurposing Collaboratory (CDRC). The National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), is also supporting the public-private partnership, which aims to create a network connecting major treatment centers, academic institutions and researchers, private practitioners, government facilities and health care professionals around the world.

Get the full story on our sister site, Drug Discovery & Development.

Read more
  • 0

FDA clears Masimo respiration sensor

Masimo (NSDQ:MASI) announced today that its Centroid wireless orientation, activity and respiration rate sensor received FDA clearance.

Centroid is a wearable sensor designed to monitor patient position in an effort to avoid preventable pressure ulcers, while also alerting clinicians to sudden movements, such as fall-like events. The device also detects chest movements to continuously provide respiration rate, offering data that could inform care decisions.

When paired with the Root patient monitoring and connectivity platform via Bluetooth, Centroid helps to track posture, orientation and activity. Data from these trackings can be displayed on Root in multiple ways, giving clinicians options in assessing protocols regarding tissue stress and patient needs.

Centroid, which can identify if a patient is lying down, standing, sitting upright, walking, or may have fallen, can also measure respiration accurately to within three respirations per minute (RPM) i…

Read more
  • 0

FDA OKs Circadia’s radar-powered tool in battle against COVID-19

Circadia’s C100 System [Image courtesy of Circadia]

Healthcare staff monitoring COVID-19 patients for respiratory distress will have a new radar-powered tool at their disposal thanks to an expedited FDA clearance for Circadia Health.

London-based Circadia Health announced today the agency gave a green light to its Contactless Respiration Rate (CResp) monitoring systems and c100 device.

“Our C100 uses radar to wirelessly look at your breathing pattern from up to four feet away,” says Fares Siddiqui, co-founder and CEO of Circadia, told the DeviceTalks Weekly podcast. “From that we can pick up your respiratory rate and patterns and then apply machine learning in order to predict and prevent respiratory complications.”

For example, Siddiqui said, “breathlessness” is one of the early signs of distress in COVID-19 patients. “We can pick that up and enable …

Read more
  • 0

FDA OKs Circadia’s radar-powered tool in battle against COVID-19

Circadia’s C100 System [Image courtesy of Circadia]

Healthcare staff monitoring COVID-19 patients for respiratory distress will have a new radar-powered tool at their disposal thanks to an expedited FDA clearance for Circadia Health.

London-based Circadia Health announced today the agency gave a green light to its Contactless Respiration Rate (CResp) monitoring systems and c100 device.

“Our C100 uses radar to wirelessly look at your breathing pattern from up to four feet away,” says Fares Siddiqui, co-founder and CEO of Circadia, told the DeviceTalks Weekly podcast. “From that we can pick up your respiratory rate and patterns and then apply machine learning in order to predict and prevent respiratory complications.”

For example, Siddiqui said, “breathlessness” is one of the early signs of distress in COVID-19 patients. “We can pick that up and enable …

Read more
  • 0

Abbott touts new data for its minimally invasive structural heart therapies

Abbott (NYSE:ABT) today announced late-breaking data on some of its structural heart disease products.

The data listed findings on the MitraClip system for transcatheter mitral valve repair, the TriClip system for transcatheter tricuspid valve repair and the Tendyne transcatheter mitral valve implantation system for mitral valve replacement.

Clinical and real-world data showed that transcatheter devices can dramatically change treatment approaches for complex cardiac conditions. The data also showed continuous positive outcomes for less invasive transcatheter therapies, further emphasizing the company’s commitment to advancing new treatment options for mitral regurgitation and tricuspid regurgitation.

MitraClip was shown to have leading safety and effectiveness. With real-world outcomes from four separate analyses, the device showed significant mitral regurgitation and reduction was achieved with the MitraClip NTR/XTR Systems in patients with prima…

Read more
  • 0

Study: Patients return to work at similar times following two common spinal surgeries

There is no significant difference in the amount of time patients need to return to work following minimally invasive lumbar decompression surgery and minimally invasive lumbar spine fusion surgery, according to a new study.

The study, performed by Hospital of Special Surgery researchers in New York City, found that patients in both surgery groups were able to discontinue narcotic pain medication within a week of surgery. Patients who received MI lumbar decompression surgery resumed driving four days sooner than MI spine fusion patients.

“Our study is the first of its kind to look at the return to activities and discontinuation of narcotic pain medication after single-level lumbar decompression or single-level lumbar spine fusion performed with a minimally invasive technique,” Dr. Sheeraz Qureshi, one of the researchers and an HSS spine surgeon, said in a news release. “In our study, all the patients in both groups were able to resume driving …

Read more
  • 0

Texas governor halts elective procedures in populous counties

Texas Medical Center in Houston is among the hospitals ordered to halt elective procedures to slow the spread of COVID-19. (Image from Visit Houston Texas)

Citing the need to preserve hospital beds for COVID-19 patients, Texas Gov. Greg Abbott today issued an executive order halting elective medical procedures in the state’s four most heavily populated counties .

The order, issued this morning, covers the counties of Bexar, Dallas, Harris and Travis counties. Bexar County includes the city of San Antonio. Houston is in Harris County and Travis County includes Austin.

COVID-19 cases hit a new high over the past 13 days, according to a report by an KXAS in Fort Worth. The number of coronavirus patients in Texas hospitals reached 4,389 on Wednesday, up from 1,784 on June 1, the television station reported. Abbott also halted the reopening of the Texas economy.

“As Texas faces a rise in COVID…

Read more
  • 0

Moderna, Catalent partner on COVID-19 vaccine candidate manufacturing

Moderna (NSDQ:MRNA) and Catalent (NYSE:CTLT) today announced a collaboration for large-scale, commercial fill-finish manufacturing of Moderna’s mRNA-based COVID-19 vaccine candidate (mRNA-1273) at Catalent’s biologics facility in Bloomington, Ind.

Catalent will provide vial filling and packaging capacity, as well as additional staffing required for 24×7 manufacturing operations at the site to support production of an initial 100 million doses intended to supply the U.S. market starting in the third quarter of 2020. The companies said they are in discussions to secure fill-finish capacity for continued production of hundreds of millions of additional doses. Somerset, N.J.-based Catalent will also provide clinical supply services from its facilities in Philadelphia, including packaging and labeling, as well as storage and distribution to support Moderna’s Phase 3 clinical study for this candidate.

Get the full story on our sister site, Pharmaceutical Processing W…

Read more
  • 0